Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Medicare
Study shows caps on Medicare prescription drug benefits result in unfavorable outcomes
June 23rd, 2006
In a study that looked at Medicare + Choice (a program that preceded Medicare Advantage and Part D coverage) researchers concluded that a cap on drug benefits for Medicare patients reduced spending on, and consumption of, prescription drugs and was associated with unfavorable clinical outcomes. The authors also found that capped drug coverage failed to save money overall. These are the findings of a study in the New England Journal of Medicine. The study, by investigators with Kaiser Permanente's Division of Research in Oakland, Calif., the University of California San Francisco and Harvard University, followed more than 157,000 Medicare +...
Source: Biotech Law Weekly (2006-06-23)
|
